Skip to main content

Table 13 Antimicrobial management of patients

From: The reliability of POCUS in the diagnosis of community-acquired pneumonia in critically ill pediatric patients: a cross-sectional study

  

N (%)

Empirical antibiotic

Meropenem and azithromycin

1 (2.4%)

Amphotericin B

1 (2.4%)

Ampicillin/sulbactam, amikacin, and oseltamivir

1 (2.4%)

Ampicillin/sulbactam and gentamicin

1 (2.4%)

Ampicillin/sulbactam and amikacin

23 (54.8%)

Ampicillin/sulbactam and ceftazidime

1 (2.4%)

Ampicillin/sulbactam and ceftriaxone

2 (4.8%)

Ampicillin/sulbactam, amikacin, and clarithromycin

1 (2.4%)

Cefepime and clarithromycin

1 (2.4%)

Ceftriaxone

4 (9.5%)

Ceftriaxone and azithromycin

1 (2.4%)

Imipenem and amikacin

1 (2.4%)

Vancomycin and meropenem

1 (2.4%)

Vancomycin, meropenem, and fluconazole

3 (7.1%)

  1. N Number